A?vaccine?is a biological preparation that provides active acquired immunity to a particular?infectious?disease.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Infectious Vaccines industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Preventive vaccine
Therapeutic vaccine
Market Segment by Product Application
Adults
Pediatrics
Finally, the report provides detailed profile and data information analysis of leading company.
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Infectious Vaccines consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Infectious Vaccines market by identifying its various subsegments.
3.Focuses on the key global Infectious Vaccines manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Infectious Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Infectious Vaccines submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Infectious Vaccines Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Infectious Vaccines Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Infectious Vaccines Segment by Type
2.1.1 Preventive vaccine
2.1.2 Therapeutic vaccine
2.2 Market Analysis by Application
2.2.1 Adults
2.2.2 Pediatrics
2.3 Global Infectious Vaccines Market Comparison by Regions (2017-2027)
2.3.1 Global Infectious Vaccines Market Size (2017-2027)
2.3.2 North America Infectious Vaccines Status and Prospect (2017-2027)
2.3.3 Europe Infectious Vaccines Status and Prospect (2017-2027)
2.3.4 China Infectious Vaccines Status and Prospect (2017-2027)
2.3.5 Japan Infectious Vaccines Status and Prospect (2017-2027)
2.3.6 Southeast Asia Infectious Vaccines Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Infectious Vaccines Industry Impact
2.5.1 Infectious Vaccines Business Impact Assessment - Covid-19
2.5.2 Market Trends and Infectious Vaccines Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Infectious Vaccines Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Infectious Vaccines Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Infectious Vaccines Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Infectious Vaccines Manufacturer Market Share
3.5 Top 10 Infectious Vaccines Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Infectious Vaccines Market
3.7 Key Manufacturers Infectious Vaccines Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Infectious Vaccines Industry Key Manufacturers
4.1 CSL Limited (Australia)
4.1.1 Compan Detail
4.1.2 CSL Limited (Australia) Infectious Vaccines Product Introduction, Application and Specification
4.1.3 CSL Limited (Australia) 130 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 CSL Limited (Australia) News
4.2 Bavarian Nordic (Denmark)
4.2.1 Compan Detail
4.2.2 Bavarian Nordic (Denmark) Infectious Vaccines Product Introduction, Application and Specification
4.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 CSL Limited (Australia) News
4.3 GlaxoSmithKline plc. (U.K.)
4.3.1 Compan Detail
4.3.2 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Introduction, Application and Specification
4.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 GlaxoSmithKline plc. (U.K.) News
4.4 Emergent Bio Solutions Inc. (U.S.)
4.4.1 Compan Detail
4.4.2 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Introduction, Application and Specification
4.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Emergent Bio Solutions Inc. (U.S.) News
4.5 MedImmune LLC (U.S.)
4.5.1 Compan Detail
4.5.2 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Introduction, Application and Specification
4.5.3 MedImmune LLC (U.S.) Infectious Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 MedImmune LLC (U.S.) News
4.6 Johnson and Johnson (U.S.)
4.6.1 Compan Detail
4.6.2 Johnson and Johnson (U.S.) Infectious Vaccines Product Introduction, Application and Specification
4.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Johnson and Johnson (U.S.) News
4.7 Novartis AG (Switzerland)
4.7.1 Compan Detail
4.7.2 Novartis AG (Switzerland) Infectious Vaccines Product Introduction, Application and Specification
4.7.3 Novartis AG (Switzerland) Infectious Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Merck and Company (U.S.)
4.8.1 Compan Detail
4.8.2 Merck and Company (U.S.) Infectious Vaccines Product Introduction, Application and Specification
4.8.3 Merck and Company (U.S.) Infectious Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Merck and Company (U.S.) News
4.9 Sanofi Pasteur (France)
4.9.1 Compan Detail
4.9.2 Sanofi Pasteur (France) Infectious Vaccines Product Introduction, Application and Specification
4.9.3 Sanofi Pasteur (France) Infectious Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Sanofi Pasteur (France) News
4.10 Pfizer Inc. (U.S.)
4.10.1 Compan Detail
4.10.2 Pfizer Inc. (U.S.) Infectious Vaccines Product Introduction, Application and Specification
4.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Pfizer Inc. (U.S.) News
5 Global Infectious Vaccines Market Segment by Big Type
5.1 Global Infectious Vaccines Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Infectious Vaccines Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Infectious Vaccines Revenue and Market Share by Big Type (2017-2022)
5.2 Preventive vaccine Sales Growth Rate and Price
5.2.1 Global Preventive vaccine Sales Growth Rate (2017-2022)
5.2.2 Global Preventive vaccine Price (2017-2022)
5.3 Therapeutic vaccine Sales Growth Rate and Price
5.3.1 Global Therapeutic vaccine Sales Growth Rate (2017-2022)
5.3.2 Global Therapeutic vaccine Price (2017-2022)
6 Global Infectious Vaccines Market Segment by Big Application
6.1 Global Infectious Vaccines Sales Market Share by Big Application (2017-2022)
6.2 Adults Sales Growth Rate (2017-2022)
6.3 Pediatrics Sales Growth Rate (2017-2022)
7 Global Infectious Vaccines Forecast
7.1 Global Infectious Vaccines Revenue, Sales and Growth Rate (2022-2027)
7.2 Infectious Vaccines Market Forecast by Regions (2022-2027)
7.2.1 North America Infectious Vaccines Market Forecast (2022-2027)
7.2.2 Europe Infectious Vaccines Market Forecast (2022-2027)
7.2.3 China Infectious Vaccines Market Forecast (2022-2027)
7.2.4 Japan Infectious Vaccines Market Forecast (2022-2027)
7.2.5 Southeast Asia Infectious Vaccines Market Forecast (2022-2027)
7.2.6 Other Regions Infectious Vaccines Market Forecast (2022-2027)
7.3 Infectious Vaccines Market Forecast by Type (2022-2027)
7.3.1 Global Infectious Vaccines Sales Forecast by Type (2022-2027)
7.3.2 Global Infectious Vaccines Market Share Forecast by Type (2022-2027)
7.4 Infectious Vaccines Market Forecast by Application (2022-2027)
7.4.1 Global Infectious Vaccines Sales Forecast by Application (2022-2027)
7.4.2 Global Infectious Vaccines Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Infectious Vaccines Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Infectious Vaccines Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Infectious Vaccines
Figure Market Concentration Ratio and Market Maturity Analysis of Infectious Vaccines
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Infectious Vaccines Market Size by Big Type
Figure Global Market Share of Infectious Vaccines by Big Type in 2021
Figure Preventive vaccine Picture (2017-2022)
Global Infectious Vaccines Market Size by Big Application
Table Global Infectious Vaccines Market Size by Application
Figure Global Infectious Vaccines Market Share by Big Application in 2021
Figure Adults Picture
Figure Pediatrics Picture
Table Global Infectious Vaccines Comparison by Regions (M USD) (2017-2027)
Figure Global Infectious Vaccines Market Size (Million US$) (2017-2027)
Figure North America Infectious Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Infectious Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure China Infectious Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Infectious Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Infectious Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Infectious Vaccines Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Infectious Vaccines Sales by Manufacturer (2017-2022)
Figure Global Infectious Vaccines Sales Market Share by Manufacturer in 2021
Table Global Infectious Vaccines Revenue by Manufacturer (2017-2022)
Figure Global Infectious Vaccines Revenue Market Share by Manufacturer in 2021
Table Global Infectious Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Infectious Vaccines Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Infectious Vaccines Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Infectious Vaccines Market
Table Key Manufacturers Infectious Vaccines Product Type
Table Mergers & Acquisitions Planning
Table CSL Limited (Australia) Company Profile
Table Infectious Vaccines Product Introduction, Application and Specification of CSL Limited (Australia)
Table Infectious Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Bavarian Nordic (Denmark) Company Profile
Table Infectious Vaccines Product Introduction, Application and Specification of Bavarian Nordic (Denmark)
Table Infectious Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bavarian Nordic (Denmark) Recent Development
Table GlaxoSmithKline plc. (U.K.) Company Profile
Table Infectious Vaccines Product Introduction, Application and Specification of GlaxoSmithKline plc. (U.K.)
Table Infectious Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline plc. (U.K.) Main Business
Table GlaxoSmithKline plc. (U.K.) Recent Development
Table Emergent Bio Solutions Inc. (U.S.) Company Profile
Table Infectious Vaccines Product Introduction, Application and Specification of Emergent Bio Solutions Inc. (U.S.)
Table Infectious Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Emergent Bio Solutions Inc. (U.S.) Main Business
Table Emergent Bio Solutions Inc. (U.S.) Recent Development
Table Emergent Bio Solutions Inc. (U.S.) Main Business
Table Emergent Bio Solutions Inc. (U.S.) Recent Development
Table MedImmune LLC (U.S.) Company Profile
Table Infectious Vaccines Product Introduction, Application and Specification of MedImmune LLC (U.S.)
Table Infectious Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table MedImmune LLC (U.S.) Main Business
Table MedImmune LLC (U.S.) Recent Development
Table Johnson and Johnson (U.S.) Company Profile
Table Infectious Vaccines Product Introduction, Application and Specification of Johnson and Johnson (U.S.)
Table Infectious Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson and Johnson (U.S.) Main Business
Table Johnson and Johnson (U.S.) Recent Development
Table Novartis AG (Switzerland) Company Profile
Table Infectious Vaccines Product Introduction, Application and Specification of Novartis AG (Switzerland)
Table Infectious Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis AG (Switzerland) Main Business
Table Novartis AG (Switzerland) Recent Development
Table Merck and Company (U.S.) Company Profile
Table Infectious Vaccines Product Introduction, Application and Specification of Merck and Company (U.S.)
Table Infectious Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck and Company (U.S.) Main Business
Table Merck and Company (U.S.) Recent Development
Table Sanofi Pasteur (France) Company Profile
Table Infectious Vaccines Product Introduction, Application and Specification of Sanofi Pasteur (France)
Table Infectious Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Pasteur (France) Main Business
Table Sanofi Pasteur (France) Recent Development
Table Pfizer Inc. (U.S.) Company Profile
Table Infectious Vaccines Product Introduction, Application and Specification of Pfizer Inc. (U.S.)
Table Infectious Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Inc. (U.S.) Main Business
Table Pfizer Inc. (U.S.) Recent Development
Figure Global Infectious Vaccines Sales and Growth Rate (2017-2022)
Figure Global Infectious Vaccines Revenue and Growth Rate (2017-2022)
Table Global Infectious Vaccines Sales by Regions (2017-2022)
Figure Global Infectious Vaccines Sales Market Share by Regions in 2021
Table Global Infectious Vaccines Revenue by Regions (2017-2022)
Figure Global Infectious Vaccines Revenue Market Share by Regions in 2021
Figure North America Infectious Vaccines Sales and Growth Rate (2017-2022)
Figure Europe Infectious Vaccines Sales and Growth Rate (2017-2022)
Figure China Infectious Vaccines Sales and Growth Rate (2017-2022)
Figure Japan Infectious Vaccines Sales and Growth Rate (2017-2022)
Figure Southeast Asia Infectious Vaccines Sales and Growth Rate (2017-2022)
Figure Other Regions Infectious Vaccines Sales and Growth Rate (2017-2022)
Table Global Infectious Vaccines Sales by Big Type (2017-2022)
Table Global Infectious Vaccines Sales Market Share by Big Type (2017-2022)
Figure Global Infectious Vaccines Sales Market Share by Big Type in 2019
Table Global Infectious Vaccines Revenue by Big Type (2017-2022)
Table Global Infectious Vaccines Revenue Market Share by Big Type (2017-2022)
Table Global Infectious Vaccines Revenue Market Share by Big Type in 2019
Figure Global Preventive vaccine Sales Growth Rate (2017-2022)
Figure Global Preventive vaccine Price (2017-2022)
Figure Global Therapeutic vaccine Sales Growth Rate (2017-2022)
Table Global Infectious Vaccines Sales by Big Application (2017-2022)
Table Global Infectious Vaccines Sales Market Share by Big Application (2017-2022)
Figure Global Infectious Vaccines Sales Market Share by Big Application in 2019
Figure Global Adults Sales Growth Rate (2017-2022)
Figure Global Pediatrics Sales Growth Rate (2017-2022)
Figure Global Infectious Vaccines Sales and Growth Rate (2022-2027)
Figure Global Infectious Vaccines Revenue and Growth Rate (2022-2027)
Table Global Infectious Vaccines Sales Forecast by Regions (2022-2027)
Table Global Infectious Vaccines Market Share Forecast by Regions (2022-2027)
Figure North America Sales Infectious Vaccines Market Forecast (2022-2027)
Figure Europe Sales Infectious Vaccines Market Forecast (2022-2027)
Figure China Sales Infectious Vaccines Market Forecast (2022-2027)
Figure Japan Sales Infectious Vaccines Market Forecast (2022-2027)
Figure Southeast Asia Sales Infectious Vaccines Market Forecast (2022-2027)
Figure Other Regions Sales Infectious Vaccines Market Forecast (2022-2027)
Table Global Infectious Vaccines Sales Forecast by Type (2022-2027)
Table Global Infectious Vaccines Market Share Forecast by Type (2022-2027)
Table Global Infectious Vaccines Sales Forecast by Application (2022-2027)
Table Global Infectious Vaccines Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Infectious Vaccines
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Infectious Vaccines Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Infectious Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Infectious Vaccines Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Infectious Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Infectious Vaccines Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Infectious Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Infectious Vaccines Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Infectious Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)